Takeda Pharmaceutical Co. (TAK) NEW YORK STOCK EXCHANGE INC.
$13.22 (0.09) (-0.68%)
Market Cap: $41.84B
As of 05/17/24 04:00 PM EDT. Market closed.
Takeda Pharmaceutical Co. (TAK)
NEW YORK STOCK EXCHANGE INC.
$13.22
(0.09) (-0.68%)
Market Cap: $41.84B
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by ... read more
COMPANY PROFILE
Sector
Industry
CEO
Christophe Weber
Full Time Employees
48,000
Sector
Industry
CEO
Christophe Weber
Full Time Employees
48,000
URL
Address
4F, 2-1-1, Nihombashihon-cho, Tokyo To, Chuo Ku, 103-8668.
PRICE CHART FOR TAKEDA PHARMACEUTICAL CO
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$13.26
Previous Close
$13.31
Days Range
$13.21 - $13.28
52 week range
$12.77 - $16.14
Volume
1,009,727
Avg. Volume (30 days)
1,459,813
Market Cap
$41.84B
Dividend Yield
2.41%
P/E
31.48
Shares Outstanding
3,164,837,450
Open
$13.26
Previous Close
$13.31
Days Range
$13.21 - $13.28
52 week range
$12.77 - $16.14
Volume
1,009,727
Avg. Volume (30 days)
1,459,813
Market Cap
$41.84B
Dividend Yield
2.41%
P/E
31.48
Shares Outstanding
3,164,837,450
FINANCIAL STATEMENTS FOR TAKEDA PHARMACEUTICAL CO
LOADING...
FUNDS WITH A POSITION IN TAKEDA PHARMACEUTICAL CO
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
CAPITAL RESEARCH GLOBAL INVESTORS | 13,121,930 | 0.04% | -8.22% | Growth At A Reasonable Price |
RENAISSANCE TECHNOLOGIES LLC | 3,118,200 | 0.07% | -6.29% | Other |
BRANDES INVESTMENT PARTNERS, LP | 2,902,507 | 0.52% | 9.48% | Value |
BLACKROCK INC. | 1,994,588 | 0.00064% | 12.57% | Other |
TFG ASSET MANAGEMENT GP LTD | 1,903,662 | 6.54% | Exited | Event Driven, Other |
D. E. SHAW & CO., INC. | 354,299 | 0.00421% | 64.82% | Other |
AQR CAPITAL MANAGEMENT LLC | 35,474 | 0.00084% | New | Other |
TUDOR INVESTMENT CORP ET AL | 18,724 | 0.00215% | Exited | Event Driven, Other |
BALYASNY ASSET MANAGEMENT L.P. | 15,354 | 0.00037% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR TAKEDA PHARMACEUTICAL CO
STOCK BUYBACKS FOR TAKEDA PHARMACEUTICAL CO
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0%
1Q
09/30/2023
0.92%
2Q
06/30/2023
0.92%
3Q
03/31/2023
1.20%
4Q
12/31/2022
1.20%
5Q
09/30/2022
1.20%
6Q
06/30/2022
1.20%
7Q
03/31/2022
0.35%
8Q
12/31/2021
0.35%
9Q
09/30/2021
0.35%
10Q
06/30/2021
0.35%
11Q
03/31/2021
0.72%
12Q
12/31/2020
0.72%
13Q
09/30/2020
0.72%
14Q
06/30/2020
0.72%
15Q
03/31/2020
0.25%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TAKEDA PHARMACEUTICAL CO
LOADING...